CompletedNot applicableNCT04995627
Salt Supplementation in Gitelman Syndrome
Studying Gitelman syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Radboud University Medical Center
- Principal Investigator
- Tom Nijenhuis, MD PhDRadboud University Medical Center
- Intervention
- Salt (NaCl)(dietary_supplement)
- Enrollment
- 21 enrolled
- Eligibility
- 16 years · All sexes
- Timeline
- 2021 – 2024
Study locations (3)
- University Hospital of University of Campania "L. Vanvitelli", Naples, Italy
- Radboudumc, Nijmegen, Gelderland, Netherlands
- Erasmus MC, Rotterdam, South Holland, Netherlands
Collaborators
Dutch Kidney Foundation
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04995627 on ClinicalTrials.govOther trials for Gitelman syndrome
Additional recruiting or active studies for the same condition.